The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a widespread yet lesser-known respiratory virus — and it is contagious. It transmits through inhalation or contact with respiratory ...

The virus causes an infection in the lungs and airways, with most people likely to experience mild to severe cold-like symptoms – 9266 cases of RSV have already been reported in Queensland this ...

Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...

Germany's Robert Koch Institute (RKI) for infectious diseases has declared the country's RSV wave officially over. RSV, or ...

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...

Synagis is the only approved preventative medicine for serious lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) in high-risk infants. MEDI8897 is a follow-on ...

HHS’s new initiative also aims to develop universal coronavirus vaccines that could provide protection against not just the virus that causes Covid-19 – SARS-CoV-2 – but its cousins SARS-CoV ...

The monoclonal antibody nirsevimab, designed to mimic natural antibodies, significantly reduces severe RSV-related ...

H5N1 bird flu is spreading rapidly among US dairy farms since March 2024. Over 1,000 dairy herds have been affected, with 70 human infections reported. The CDC states the risk to the general ...